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INTRODUCTION
Endometriosis is a benign gynecological disorder
characterised by the presence of endometrial
glands and stroma cells that grows outside the
uterine cavity and is associated with pelvic pain
and infertility. Ectopic endometrial tissue normally
found in the pelvic cavity, but can also exist in
all parts of the body. Signs and symptoms of
endometriosis vary, tend to be progressive and
recurrent and often creates difficulties for women
and doctors.1
Until now, the aetiology and pathogenesis of
endometriosis are not known with certainty.
Endometriosis is found in about 3-10% of the
female population of reproductive age. The
incidence of endometriosis in women with dys-
menorrheal is 60-80%, 30-50% of women with
complaints of abdominal pain, and 30-40 women
with infertility. This incidence is high enough to
put endometriosis as one of the main repro-
ductive problems nowaday. Additionally, the
pathophysiology and the impact of clinical
disorders caused by endometriosis and its
management is still not as expected.2 There is
63.6% incidence of endometriosis of infertility
cases. At the Dr. Soetomo General Hospital
obtained a trend of increased incidence of
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Abstrak
Tujuan: Menentukan peran matriks metalloproteinase-2 (MMP-
2) pada serum dan cairan peritoneum pasien endometriosis.
Metode: Desain penelitan dengan metode potong lintang dilakukan di
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endometriosis with 23% in 1980, 37% in 1990
and reached 50% in 2002.3
The cause of endometriosis has yet known with
certainty. There are several theories put forward
about the cause of endometriosis, one of the most
common theories of the cause of endometriosis is
regurgitation of menstrual blood, which allows the
deployment of endometrial cells into the peritoneal
cavity. Peritoneal endometriosis, which is the most
common form of endometriosis occurs due to
increase of metalloproteinases lesions. Red endo-
metriosis is the most active type of endometriosis.
In this type, there is increasing activity of angio-
genesis which result in increase of blood flow in
the endometriosis lesions. It also explains the high
incidence of menstrual pain. Macrophages and
other immuno competent cells surrounding the
endometriosis lesions and issuing various
types of cytokines catabolic intended to cause
chronic inflammatory reactions and stimulate
the formation of fibrotic tissue.4
The process of angiogenesis in excess endo-
metrial tissue suspected as an important
mechanism in the pathogenesis of endometriosis.
The process of angiogenesis in addition to a role
in the onset of endometriosis also plays a role in
implantation, tissue remodeling and the process of
metastasis.2 Lately, research on endometriosis
involving elements of peritoneal fluid and the
process of angiogenesis open many new horizons
of the pathogenesis of endometriosis, where the
involvement of autocrine and paracrine factors
thought to play a major role.5
In addition to VEGF, transforming growth
factor-beta 1 (TGF-1) and soluble endoglin;
matrix metalloproteinase (MMP) is also widely
studied as an angiogenesis factor in the occurrence
of endometriosis. In a normal menstrual cycle, i.e.
the inhibitors of MMPs and tissue inhibitors of
matrix metalloproteinases (TIMPs), play a
significant role in the remodelling of the endo-
metrial tissue. MMP also plays an important
role in physiological and pathological processes in
humans which are embryogenesis, angiogenesis,
wound healing and metastases.6
A previous study by Salata, suggests the
approximate concentration of serum MMP-2,
MMP-9, TIMP-1 and TIMP-2 did not reflect the
severity of endometriosis, although MMP activity
increased in the peritoneal fluid of women with
endometriosis.7
Further research by Weigel et al., reported there
is a difference between MMP-2, MMP-9 and PCNA
in stages of endometriosis and endometrial cancer.8
Research by Jana et al. found MMP-2 plays an
important role in pathological angiogenesis, and an
imbalance ratio of MMP-2 and TIMP-2 are thought
to modulate angiogenesis during the early
development of endometriosis. These markers
may assist in the evaluation of aggressiveness and
invasive ability of endometriosis at different
locations. The results obtained could explain the
pathogenesis  o f  endometr ios is  and the
development of endometriosis therapy.9
Research on the role of MMP-2 as a marker of
angiogenesis in endometriosis using serum and
peritoneal fluid has never yet been studied in South
Sulawesi. Therefore, the authors are interested in
conducting research that aims to determine the
relationship between levels of MMP-2 in serum
and peritoneal fluid and the development of endo-
metriosis.
METHOD
The study was conducted at Dr. Wahidin Sudiro-
husodo Hospital, Makassar and other networking
Hospitals Department of Obstetrics and Gyneco-
logy, Faculty of Medicine, Universitas Hasanuddin
in Makassar began in May 2015 until May 2016.
The method used is observational with a cross-
sectional design. The study population was all
patients who underwent laparoscopic in Dr.
Wahidin Sudirohusodo Hospital, Makassar and
other networking Hospitals Department of
Obstetrics and Gynecology, Faculty of Medicine,
Universitas Hasanuddin in Makassar. Samples are
all patients with endometriosis that underwent
laparoscopic with various operating indications
that met the inclusion criteria and had signed
a letter of approval. The sample in this study
amounted to 29 women with endometriosis and
21 controls.
Doing anamnesis towards mothers willing to
participate in this study and have filled the
approval, noted on the questionnaire sheet.
Recording the identity of the patient including
their name, age, parity and the first day of the last
menstrual period. Before laparoscopy performed
blood sample for examination of serum MMP-2. At
the time of laparoscopy peritoneal fluid is taken for
examination of peritoneal fluid MMP-2. Laboratory
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tests for the levels of MMP-2 serum and peritoneal
fluid is carried out in the Laboratory of Micro-
biology Teaching Hospital Universitas Hasanuddin,
Makassar.
To determine differences in the levels of MMP-2
well in the control group as well as in endo-
metriosis used Fisher’s exact test, Mann Whitney,
independent T, and Spearman association. The
data were processed using SPSS 18. Then the data
are presented in tabular form with a p value less
than 0.05 was considered significantly available.
RESULTS
Research has been conducted with cross-sectional
design to determine the relationship between
levels of MMP-2 in serum and peritoneal fluid with
the incidence of endometriosis. The study was
conducted in public service agency of Dr. Wahidin
Sudirohusodo, Hospital Makassar and networking
Hospital Department of Obstetrics and Gynecology,
Faculty of Medicine, Universitas Hasanuddin in
Makassar began in May 2015 until May 2016.
Measurement of MMP-2 levels in serum and
peritoneal fluid were conducted on 29 women with
endometriosis and 21 controls (without endome-
triosis). Fisher test results on the characteristics
of this sample showed that there were significant
differences between infertility and dysmenorrhea
for both groups, but other characteristics did not
differ significantly (p> 0.05) (Table 1).
The results of measurements of serum level
of MMP-2 in both study groups showed a mean
serum levels of MMP-2 of 6.03  3.26 ng/ml in the
endometriosis group and 1.49  0.68 ng/ml in
controls. Serum levels of the MMP-2 endometriosis
group were higher than the control, and there is a
significant difference (p = 0.000) between the two
groups. The mean levels of MMP-2 were also
higher peritoneal fluid in endometriosis than in
controls (1.98  1.61 ng/ml vs 0.61  0.12 ng/ml),
and significantly different for the two groups (p =
0.036) (Table 2).
Table 1. Respondent Characteristic
Respondent
Characteristic
Endometriosis (n=29)
n(%)
Control (n=21)
n(%)
p
Age (year)
20-35 24 (82.8) 14 (66.7) 0.189
36-45 5 (17.2) 7 (33.3)
Marital status
Married 26 (89.7) 17 (81.0) 0.434
Not married 3 (10.3) 4 (19.0)
Body Mass Index (kg/m2)
Normal 25 (86.2) 20 (95.2) 0.383
Overweight 4 (13.8) 1 (4.8)
Infertility
Primer 16 (55.2) 8 (38.1) 0.009
Secondary 6 (20.7) 0
Not infertile 7 (24.1) 13 (61.9)
Dysmenorrhea
Yes 27 (93.1) 3 (14.3) 0.000
No 2 (6.9) 18 (85.7)
Contraception
Yes 3 (10.3) 7 (33.3) 0.073
No 26 (89.7) 14 (66.7)
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The levels of MMP-2 on the stage of endo-
metriosis showed the average serum levels of
MMP-2 in stage I-II, 3.35  1.41 ng/ml and
7.45  3.06 ng/ml in stage III-IV. The mean serum
levels of MMP-2 in stage III-IV is higher than stage
I-II, and there is a significant difference between
the two stages (p = 0.000). In peritoneal fluid, the
mean levels of MMP-2 did not differ significantly
between the two stages endometriosis’ (p> 0.05)
(Table 3).
Association test results showed there is a strong
relationship and meaning between the levels of
MMP-2 serum and endometriosis (r = 0.874;
p = 0.000), as well as the levels of MMP-2
peritoneal fluid and endometriosis (r = 0.383;
p = 0.006) (Table 4).
Table 4. The Association between MMP-2 dan Endome-
triosis Test Result
MMP­2 Level Endometriosis
r p
Serum 0.874 0.000
Peritoneal fluid 0.383 0.006
DISCUSSION
This  study shows that  infert i l i ty  and
dysmenorrheal have an effect on endometriosis
than age, marital status, BMI and contraception.
Endometriosis affects 10% of women of repro-
ductive age. Clinical symptoms are dysmenorrhea,
dyspareunia and pelvic pain, making women’s
health worsens. Patients with endometriosis often
accompanied by symptoms of dysmenorrhea and
infertility complaint. The complaint is the primary
reason the patient to see a doctor.
Research proves infertility due to endometriosis
also increased. Hadisaputra Research found that
infertility is closely related to endometriosis.
Approximately 20-40% of infertile women have
endometriosis. The overall prevalence of patients
with endometriosis in infertile women is higher
compared with fertile women. In moderate to
severe endometriosis, a higher ratio of infertile
patients than fertile patients.3,10
The average age of diagnosis of endometriosis is
between 25 to 35 years.1 As shown in this study,
the most established was in the age range of 20-35
years. Another study by Abdullah and Manuaba
found that the mean age for each case is 32 years
old and 34 years old. Although the onset can occur
during adolescence, detection is often done too
late. Peak prevalence of endometriosis is found, at
age 40, but the risk of a woman suffering from
endometriosis is 30-34 years (RR = 2.1), 35-39
years (RR = 4.4) and 40-44 years (RR = 6.1 ) at the
age range 25-29 years.2,5 Increasing age in women
affects fecundity and lowers fertility through
distortion of adnexal anatomy and overproduction
of prostaglandins, metalloproteinases, cytokines
and chemokines cause chronic inflammation that
disrupts ovarian function, tubal or endometrial so
that an interruption in the process of folliculo-
genesis, fertilisation or implantation.1,10
Table 2. MMP-2 Level in the Study Sample
Sample MMP­2 serum level(Mean  DS ng/ml) p*
MMP­2 peritoneal fluid level
(Mean  DS ng/ml) p**
Endometriosis (n=29) 6.03  3.26 0.000 1.98  1.61 0.036
Control (n=21) 1.49  0.68 0.61  0.12
*Independent T-test**Mann-Whitney test
Table 3. MMP-2 Level in Endometriosis Stage
Endometrosis
Stage n
MMP­2 serum level
(Mean  DS ng/ml) p*
MMP­2 peritoneal fluid level
(Mean  DS ng/ml) p**
I­II 10 3.35  1.41 0.000 1.17  1.01 0.119
III­IV 19 7.45  3.06 2.41  1.72
*Independent T-test**Mann-Whitney test
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Although some studies suggest that obesity is
associated with the incidence of endometriosis but
in this study only obtained five patients with a
BMI> 25. In the study by Manuaba in Makassar
found that normal body mass index was also
obtained in most cases of endometriosis.5
Research by Vercellini et al. showed that there
is decreased in the incidence risk of endometriosis
in women who are new to the contraceptive pills
but increased in women who had used the contra-
ceptive pills.11 Research by Chapron et al. shows
there is no relationship between the new user to
use contraceptive pills with endometriosis. This
study also indicates that the history of the use of
contraceptive pills for primary dysmenorrhea
related diagnosis endometriosis surgery at a later
date, especially on deep infiltrating endometriosis.
However, this does not mean that the use of
contraceptive pills increases the risk of develop-
ment of endometriosis. Contraceptive pill usage
history can serve as a marker for women with
endometriosis and deep infiltrating endometriosis
while IUD use of the user’s current (0-12 months)
than former users (49-72 months), will increase
the risk of endometriosis in former users.12 Other
research by Rambulangi et al., shows the levels of
MMP-2 serum and peritoneal fluid of women
endometriosis is higher than the control. In this
study, also obtained the levels of MMP-2 in serum
and peritoneal higher in endometriosis than in
controls.13
Elevated levels of MMP-2 allegedly due to the
stimulation by inflammatory factors and activation
MT1 MMP. This is supported by several studies
showing an increase in MMP-2 along with some
marker that is associated with inflammation and
angiogenesis such as IL-6, TGF-, TNF-, MIF and
VEGF.14 This study also shows the levels of MMP-2
serum and peritoneal fluid of endometriosis is
higher in women with stage III-IV than stage I-II,
although the peritoneal fluid did not differ
significantly. Association test results showed there
is a strong association between high levels of
MMP-2 serum and peritoneal fluid with endo-
metriosis that may indicate the involvement of
MMP-2 in the pathogenesis of endometriosis. The
results are consistent with research Malvezzi et al.,
also found elevated levels of MMP-2 serum of
infertile women with stage III-IV higher than
stage I-II.15
Pathogenesis of endometriosis regarding
attachment scheme-aggression-angiogenesis (AAA)
has been accepted. In this process, the role of
MMP uncontested. MMP can degrade collagen and
extracellular matrix components. The formation of
the ectopic endometrial tissue is mediated by
factors that facilitate adhesion to the peritoneal
cavity, cell growth, increased aromatase activity,
angiogenic, neurogenic/lymphogenic factors, and
reinforced by the activity of MMP. MMP-2 plays an
important role in the adhesion and proliferation of
loose menstrual tissue as the pathogenesis of
endometriosis. Increased circulation of MMP-2 in
patients with severe pelvic endometriosis through
the mechanism of major tissue remodeling
happened due to disease progression, as a result
of increased activity of MMP-2 systemic and local,
as well as the high activity of ectopic aromatase
tissues can increase the production of MMP-2,
which can facilitate the invasion and progression
of the disease, so that MMP-2 correlated with
increasing degrees of endometriosis.15
CONCLUSIONS
The researchers concluded that there is a signifi-
cant increase in the levels of both-2 serum and
peritoneal fluid in patients with endometriosis
compared to women who did not suffer from
endometriosis. Also found the levels of MMP-2
were higher in severe endometriosis compared
with mild endometriosis, but the peritoneal fluid
has not found significant differences. The levels of
MMP-2 serum or peritoneal fluid is significantly
correlated with the incidence of endometriosis.
RECOMMENDATIONS
Researchers suggested that to do further study on
MMP-2 and other endometriosis markers in
determining the diagnosis and therapy develop-
ment of endometriosis.
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